Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Change in Cash (2016 - 2026)

Intellia Therapeutics has reported Change in Cash over the past 12 years, most recently at -$17.5 million for Q1 2026.

  • Quarterly Change in Cash rose 68.01% to -$17.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2026, up 105.12% year-over-year, with the annual reading at -$35.2 million for FY2025, 6.25% up from the prior year.
  • Change in Cash was -$17.5 million for Q1 2026 at Intellia Therapeutics, up from -$39.8 million in the prior quarter.
  • Over five years, Change in Cash peaked at $385.7 million in Q4 2022 and troughed at -$229.4 million in Q1 2023.
  • The 5-year median for Change in Cash is -$6.9 million (2022), against an average of $1.4 million.
  • Year-over-year, Change in Cash tumbled 1629.85% in 2023 and then skyrocketed 459.45% in 2025.
  • A 5-year view of Change in Cash shows it stood at $385.7 million in 2022, then tumbled by 84.61% to $59.4 million in 2023, then increased by 15.7% to $68.7 million in 2024, then crashed by 157.91% to -$39.8 million in 2025, then skyrocketed by 56.08% to -$17.5 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Change in Cash are -$17.5 million (Q1 2026), -$39.8 million (Q4 2025), and $37.2 million (Q3 2025).